OpenAI Researcher in Talks to Launch AI Drug Discovery Startup at $2B Valuation
Miles Wang, a researcher at OpenAI, is reportedly in discussions to launch a new startup focused on AI-driven drug discovery. The venture is said to be targeting a valuation of approximately $2 billion. Venture capital firm Lightspeed is in talks to lead the funding round, according to sources familiar with the matter. The development signals growing investor interest in applying artificial intelligence to pharmaceutical research and development.
This is an AI-generated summary. ShortSingh links to the original source for the complete article.


Discussion (0)
Log in to join the discussion and vote.
Log in